Harvard University, U.S.
Findings from studies by Harvard University, U.S., scientists provide new insights
Published in Pharma Investments, Ventures and Law Weekly, December 10th, 2006
This trend article about Harvard University, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Efficacious microsphere therapy for cardiac angiogenesis depends on catheterization strategy.
According to a study from the United States, "Gelatin hydrogel microspheres (GHMs) have been reported as novel non-viral vectors for gene or protein delivery (GHM therapy). However, the components of an effective catheter-based delivery strategy for GHM therapy are unknown."
"We evaluated the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Business & Finance
Angiotech Pharmaceuticals reports income of $0.19 per share - Business & Finance
Connetics reports third quarter financial results - Business & Finance
Cross Country Healthcare reports $162.9 million for third quarter 2006 - Business & Finance
Cutera reports 32% third-quarter revenue increase over same period last year - Business Update
China Medical Technologies and Chinese Academy of Sciences Institute of Acoustics form lab - Business Update
Drager Medical and Masimo announce expanded relationship - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
